Adam E Gaweda

US Patent:

20110318761, Dec 29, 2011

Filed:

Jun 23, 2011

Appl. No.:

13/167478

Inventors:

Michael L. Merchant - Louisville KY, US
Jon B. Klein - Louisville KY, US
Michael E. Brier - New Albany IN, US
Adam E. Gaweda - Louisville KY, US

Assignee:

UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. - Louisville KY

International Classification:

G01N 33/566
C07K 17/00
H01J 49/26
C07K 16/18

US Classification:

435 792, 436501, 5303879, 5303911, 250282

Abstract:

Methods for predicting a response to an erythropoietic agent in a subject include providing a biological sample from the subject, and determining an amount in the sample of at least one peptide selected from the group consisting of SEQ ID NOS: 1-17. If there is a measurable difference in the amount of the at least one peptide in the sample, when compared to a control level of the same peptide, the subject is then predicted to have a good response or a poor response to the erythropoietic agent. Kits for predicting a response to an erythropoietic agent are further provided and include one or more antibodies, or fragments thereof, that specifically recognize a peptide of SEQ ID NOS: 1-17.

US Patent:

20150247868, Sep 3, 2015

Filed:

May 14, 2015

Appl. No.:

14/712323

Inventors:

- Louisville KY, US
Jon B. Klein - Louisville KY, US
Michael E. Brier - Sellersburg IN, US
Adam E. Gaweda - Jeffersonville IN, US

International Classification:

G01N 33/68

Abstract:

Methods for predicting a response to an erythropoietic agent in a subject include providing a biological sample from the subject, and determining an amount in the sample of at least one peptide selected from the group consisting of SEQ ID NOS: 1-17. If there is a measurable difference in the amount of the at least one peptide in the sample, when compared to a control level of the same peptide, the subject is then predicted to have a good response or a poor response to the erythropoietic agent.